Laser Focused on Disrupting

Retinal Treatments

+400 Million People Suffer From Eye Disease

Age Related Macular Degeneration (AMD) is the leading cause of blindness with over 190M people affected and is proportionally increasing as the general population ages

Our Solution
 

PulseMedica is an Edmonton-based company developing a medical device to treat retinal eye diseases that affect over 400 million people worldwide. Our device consists of a state-of-the-art 3D imaging and surgical platform that allows for comprehensive patient treatment including machine learning based disease detection, surgical planning, surgical treatment, and post-surgery evaluation.

With current laser technology we will offer radically more precise treatment for wet-stage age-related macular degeneration (AMD) and diabetic retinopathy. With our next generation femtosecond laser technology, we will be offering surgical treatment for dry-stage AMD, a condition for which treatment is unavailable.

Diagnostic assist technology

01

Enhanced laser accuracy

03

02

Higher image quality than conventional methods

Executive Team

Eric Martin

Co-Founder, COO

Leader, clinician and innovator in healthcare for the past decade

Dr. Nir Katchinskiy

Co-Founder, CEO

Entrepreneur, and pioneer
of laser based medical devices.

Advisory Team

Lahav Gil

Executive Advisor

Lahav has over three decades of experience as a founder, innovator, entrepreneur, executive, and investor, mostly in the medtech space

Dr. Abdul Elezzabi

Co-Founder, Scientific Advisor

World leading pioneer in
Femtosecond laser tissue interaction

CONTACT